Efficacy and Safety Evaluation of Octreotide in the Treatment of Congenital Hyperinsulinemia

NCT05171751 · clinicaltrials.gov ↗

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Congenital Hyperinsulinaemic Hypoglycaemia
Octreotide Adverse Reaction

Interventions

DRUG: Octreotide Injection

Sponsor

Beijing Children's Hospital